41 related articles for article (PubMed ID: 14638359)
1. Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma.
Hiasa Y; Kamegaya Y; Nuriya H; Onji M; Kohara M; Schmidt EV; Chung RT
Am J Gastroenterol; 2003 Nov; 98(11):2528-34. PubMed ID: 14638359
[TBL] [Abstract][Full Text] [Related]
2. The long noncoding RNA of RMRP is downregulated by PERK, which induces apoptosis in hepatocellular carcinoma cells.
Yukimoto A; Watanabe T; Sunago K; Nakamura Y; Tanaka T; Koizumi Y; Yoshida O; Tokumoto Y; Hirooka M; Abe M; Hiasa Y
Sci Rep; 2021 Apr; 11(1):7926. PubMed ID: 33846370
[TBL] [Abstract][Full Text] [Related]
3. Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease.
Roca Suarez AA; Testoni B; Baumert TF; Lupberger J
Front Immunol; 2020; 11():624034. PubMed ID: 33613561
[TBL] [Abstract][Full Text] [Related]
4. Crosstalks between inflammasome and autophagy in cancer.
Chung C; Seo W; Silwal P; Jo EK
J Hematol Oncol; 2020 Jul; 13(1):100. PubMed ID: 32703253
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivo.
Watanabe T; Ninomiya H; Saitou T; Takanezawa S; Yamamoto S; Imai Y; Yoshida O; Kawakami R; Hirooka M; Abe M; Imamura T; Hiasa Y
Sci Rep; 2020 Mar; 10(1):5133. PubMed ID: 32198380
[TBL] [Abstract][Full Text] [Related]
6. Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.
Imai Y; Yoshida O; Watanabe T; Yukimoto A; Koizumi Y; Ikeda Y; Tokumoto Y; Hirooka M; Abe M; Hiasa Y
PLoS One; 2019; 14(2):e0212589. PubMed ID: 30794626
[TBL] [Abstract][Full Text] [Related]
7. Roles of protein kinase R in cancer: Potential as a therapeutic target.
Watanabe T; Imamura T; Hiasa Y
Cancer Sci; 2018 Apr; 109(4):919-925. PubMed ID: 29478262
[TBL] [Abstract][Full Text] [Related]
8. NDRG2 contributes to cisplatin sensitivity through modulation of BAK-to-Mcl-1 ratio.
Park S; Oh SS; Lee KW; Lee YK; Kim NY; Kim JH; Yoo J; Kim KD
Cell Death Dis; 2018 Jan; 9(2):30. PubMed ID: 29348517
[TBL] [Abstract][Full Text] [Related]
9. Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH).
Utsunomiya H; Yamamoto Y; Takeshita E; Tokumoto Y; Tada F; Miyake T; Hirooka M; Abe M; Kumagi T; Matsuura B; Ikeda Y; Hiasa Y
J Gastroenterol; 2017 Aug; 52(8):940-954. PubMed ID: 28062946
[TBL] [Abstract][Full Text] [Related]
10. Viral hepatitis: HCV compartmentalization in HCC: driver, passenger or both?
Holmes JA; Chung RT
Nat Rev Gastroenterol Hepatol; 2016 May; 13(5):254-6. PubMed ID: 27006254
[No Abstract] [Full Text] [Related]
11. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.
Cheng X; Byrne M; Brown KD; Konopleva MY; Kornblau SM; Bennett RL; May WS
Blood; 2015 Sep; 126(13):1585-94. PubMed ID: 26202421
[TBL] [Abstract][Full Text] [Related]
12. Double stranded RNA-dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma cells by activating STAT3.
Wang X; Dong JH; Zhang WZ; Leng JJ; Cai SW; Chen MY; Yang X
Oncol Lett; 2014 Dec; 8(6):2762-2768. PubMed ID: 25360179
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection.
Watanabe T; Hiasa Y; Tokumoto Y; Hirooka M; Abe M; Ikeda Y; Matsuura B; Chung RT; Onji M
PLoS One; 2013; 8(7):e67750. PubMed ID: 23844083
[TBL] [Abstract][Full Text] [Related]
14. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma.
Kunkeaw N; Jeon SH; Lee K; Johnson BH; Tanasanvimon S; Javle M; Pairojkul C; Chamgramol Y; Wongfieng W; Gong B; Leelayuwat C; Lee YS
Oncogene; 2013 Aug; 32(32):3722-31. PubMed ID: 22926522
[TBL] [Abstract][Full Text] [Related]
15. Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis.
Mohamed AA; Nada OH; El Desouky MA
Diagn Pathol; 2012 Aug; 7():103. PubMed ID: 22894766
[TBL] [Abstract][Full Text] [Related]
16. Associations among Genotype 1b Hepatitis C Virus Core Protein, Protein Kinase R, and Signal Transducer and Activator of Transcription 3.
Yan XB; Chen Z; Brechot C
Hepat Mon; 2010; 10(4):275-84. PubMed ID: 22312393
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism by which palmitate inhibits PKR autophosphorylation.
Cho H; Mukherjee S; Palasuberniam P; Pillow L; Bilgin B; Nezich C; Walton SP; Feig M; Chan C
Biochemistry; 2011 Feb; 50(6):1110-9. PubMed ID: 21192654
[TBL] [Abstract][Full Text] [Related]
18. Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2.
Yang X; Chan C
Cell Res; 2009 Apr; 19(4):469-86. PubMed ID: 19259124
[TBL] [Abstract][Full Text] [Related]
19. A Three Stage Integrative Pathway Search (TIPS) framework to identify toxicity relevant genes and pathways.
Li Z; Srivastava S; Mittal S; Yang X; Sheng L; Chan C
BMC Bioinformatics; 2007 Jun; 8():202. PubMed ID: 17570844
[TBL] [Abstract][Full Text] [Related]
20. Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication.
Hiasa Y; Blackard JT; Lin W; Kamegaya Y; Horiike N; Onji M; Schmidt EV; Chung RT
J Virol Methods; 2006 Mar; 132(1-2):195-203. PubMed ID: 16313977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
